Leerink Partnrs Estimates Kura Oncology FY2026 Earnings
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Equities research analysts at Leerink Partnrs issued their FY2026 EPS estimates for Kura Oncology in a note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang anticipates that the company will post earnings per share of ($1.05) for the year. The consensus estimate for […]
